SYNTi
Product Specifications
Target
Others
Related Pathways
Others
Bioactivity
SYNTi, a PDZ domain inhibitor, specifically targets the syndecan/syntenin protein-protein interaction, demonstrating an IC50 of 400 nM and a ligand efficiency (LE) value of 0.24. It holds potential for use in breast cancer research.
Smiles
CC(C1=CC=C(F)C(C2=CC=C(C[C@H](N3C(C4=CC=C(Br)C=C4C3)=O)C(N[C@@H](C)C(O)=O)=O)C=C2)=C1)=O
Molecular Formula
C28H24BrFN2O5
Molecular Weight
567.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1576008 1.0 µg DNA
OSTM1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details